title: Introduction and commentary: Paving the way for biosimilars in oncology.
authors.affiliation: Director of Breast Oncology Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Electronic address: abrahaj@ccf.org.
authors.forename: Jame
authors.initials: J
authors.lastname: Abraham
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000191:economics / Q000379:methods; D017048:Health Care Costs; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics
chemical_list: D000970:Antineoplastic Agents; D059451:Biosimilar Pharmaceuticals